TN2011000350A1 - Paediatric solutions comprising a beta-blocker - Google Patents

Paediatric solutions comprising a beta-blocker

Info

Publication number: TN2011000350A1
Authority: TN; Tunisia
Prior art keywords: blocker; beta; solutions; paediatric; present
Prior art date: 2009-04-21

Application number

TN2011000350A

Other languages

English (en)

Inventor

Christine Chaumont

Jean-Francois Cordoliani

Elie Leverd

Valerie Muguet

Original Assignee

Pierre Fabre Dermatologie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-21

Filing date

2011-07-15

Publication date

2013-03-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40940328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2011000350(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-07-15 Application filed by Pierre Fabre Dermatologie filed Critical Pierre Fabre Dermatologie

2013-03-27 Publication of TN2011000350A1 publication Critical patent/TN2011000350A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Seasonings (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

TN2011000350A 2009-04-21 2011-07-15 Paediatric solutions comprising a beta-blocker TN2011000350A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP09290298A EP2246044A1 (fr)	2009-04-21	2009-04-21	Solutions pédiatriques de bêta-bloquants
PCT/IB2010/051573 WO2010122442A1 (fr)	2009-04-21	2010-04-12	Solutions pédiatriques comprenant un bétabloquant

Publications (1)

Publication Number	Publication Date
TN2011000350A1 true TN2011000350A1 (en)	2013-03-27

Family

ID=40940328

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TN2011000350A TN2011000350A1 (en)	2009-04-21	2011-07-15	Paediatric solutions comprising a beta-blocker

Country Status (32)

Country	Link
US (2)	US20120035270A1 (fr)
EP (4)	EP2246044A1 (fr)
JP (1)	JP5695029B2 (fr)
KR (1)	KR101713866B1 (fr)
CN (1)	CN102405041A (fr)
AR (2)	AR076338A1 (fr)
AU (1)	AU2010240551B2 (fr)
BR (1)	BRPI1015447B1 (fr)
CA (1)	CA2755175C (fr)
CL (1)	CL2011002634A1 (fr)
CO (1)	CO6410278A2 (fr)
CY (2)	CY1119390T1 (fr)
DK (2)	DK2421504T4 (fr)
ES (2)	ES2623936T5 (fr)
GE (1)	GEP20146087B (fr)
HR (2)	HRP20170610T4 (fr)
HU (2)	HUE039937T2 (fr)
IL (1)	IL214674A (fr)
LT (2)	LT2421504T (fr)
MA (1)	MA33003B1 (fr)
MX (1)	MX337463B (fr)
NZ (1)	NZ594592A (fr)
PL (2)	PL2497461T5 (fr)
PT (2)	PT2497461T (fr)
RS (2)	RS55862B2 (fr)
RU (1)	RU2011139233A (fr)
SG (1)	SG172960A1 (fr)
SI (2)	SI2497461T2 (fr)
TN (1)	TN2011000350A1 (fr)
TW (1)	TWI429459B (fr)
UA (1)	UA107570C2 (fr)
WO (1)	WO2010122442A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2246044A1 (fr)	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Solutions pédiatriques de bêta-bloquants
MX348831B (es) *	2011-03-04	2017-06-30	Gruenenthal Gmbh	Administración parenteral de tapentadol.
JP2019142972A (ja) *	2011-03-04	2019-08-29	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	タペンタドールの非経口的投与
PT2680832T (pt)	2011-03-04	2019-10-28	Gruenenthal Gmbh	Formulação farmacêutica aquosa de tapentadol para administração oral
US9724297B2 (en)	2014-04-01	2017-08-08	Arbor Pharmaceuticals, Inc.	Sotalol compositions and uses of the same
HRP20190231T1 (hr)	2015-03-27	2019-04-05	Grünenthal GmbH	Stabilna formulacija za parenteralnu primjenu tapentadola
JP7160799B2 (ja)	2016-09-23	2022-10-25	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	タペンタドールの非経口投与用安定製剤
CN108261411B (zh) *	2016-12-30	2021-04-30	武汉科福新药有限责任公司	用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法
CN107320467A (zh) *	2017-07-21	2017-11-07	江苏云阳集团药业有限公司	一种盐酸普萘洛尔药用组合物及其制备方法
CN108299279B (zh) *	2018-02-09	2021-03-23	北京梅尔森医药技术开发有限公司	取代芳基胺醇化合物及其制备方法和用途
US11547123B2 (en) *	2019-08-16	2023-01-10	The Folger Coffee Company	Methods for reducing negative flavor attributes in coffee and compositions therefrom
WO2022071481A1 (fr)	2020-09-30	2022-04-07	日産化学株式会社	COMPLEXE HYDROSOLUBLE CONTENANT UN β-BLOQUANT ET DE LA LÉCITHINE
CN116407495A (zh) *	2023-03-09	2023-07-11	北京梅尔森医药技术开发有限公司	一种阿替洛尔口服溶液及其制备方法和应用
GB2628566A (en)	2023-03-29	2024-10-02	Novumgen Ltd	An orally rapidly disintegrating tablet of propranolol and its process of preparation
WO2025068937A1 (fr)	2023-09-30	2025-04-03	Liqmeds Worldwide Limited	Formulation liquide orale de métoprolol
CN118021718B (zh) *	2024-04-12	2024-07-02	成都瑞尔医药科技有限公司	一种盐酸普罗帕酮注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4600708A (en)	1985-07-19	1986-07-15	American Home Products Corporation	Propranolol hydrochloride liquid formulations
HU209251B (en) *	1992-03-13	1994-04-28	Synepos Ag	Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
EP0732064B1 (fr)	1995-03-15	2001-06-06	Kao Corporation	Utilisation d'un agent pour réduire l'amertume
JPH1025253A (ja) *	1996-07-12	1998-01-27	Kao Corp	苦味低減化剤及び苦味低減化法
JPH11349492A (ja) *	1998-06-03	1999-12-21	Yamanouchi Pharmaceut Co Ltd	苦味を低減した経口用医薬組成物および苦味低減化方法
JP2001342151A (ja) *	2000-03-31	2001-12-11	Eisai Co Ltd	甘味を有する薬剤組成物
AU2002258026B2 (en) *	2001-05-25	2007-08-02	Warner-Lambert Company Llc	Liquid pharmaceutical composition
EP1543831A1 (fr) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Composition de pregabaline
CA2597155A1 (fr) *	2005-02-25	2006-09-08	Biomarin Pharmaceutical Inc.	Composition pharmaceutique liquide aqueuse stable a temperature ambiante
MX2007014713A (es) *	2005-05-25	2008-02-14	Janssen Pharmaceutica Nv	Formulacion pediatrica de topiramato.
DE102006020604A1 (de) *	2006-05-02	2007-11-08	Bayer Healthcare Ag	Flüssige Arzneimittelformulierung
EP2050441A1 (fr)	2007-10-19	2009-04-22	Université Victor Segalen Bordeaux 2	Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes
HRP20150083T1 (hr) *	2008-04-25	2015-03-13	Apotex Technologies Inc.	Tekuä†a formulacija deferiprona sa ugodnim okusom
EP2246044A1 (fr)	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Solutions pédiatriques de bêta-bloquants

2009
- 2009-04-21 EP EP09290298A patent/EP2246044A1/fr not_active Withdrawn
2010
- 2010-04-12 MA MA34064A patent/MA33003B1/fr unknown
- 2010-04-12 SI SI201031741T patent/SI2497461T2/sl unknown
- 2010-04-12 KR KR1020117024721A patent/KR101713866B1/ko active Active
- 2010-04-12 CN CN2010800174060A patent/CN102405041A/zh active Pending
- 2010-04-12 HR HRP20170610TT patent/HRP20170610T4/hr unknown
- 2010-04-12 GE GEAP201012468A patent/GEP20146087B/en unknown
- 2010-04-12 RS RS20170358A patent/RS55862B2/sr unknown
- 2010-04-12 JP JP2012506607A patent/JP5695029B2/ja active Active
- 2010-04-12 SI SI201031439A patent/SI2421504T1/sl unknown
- 2010-04-12 HU HUE12155472A patent/HUE039937T2/hu unknown
- 2010-04-12 RU RU2011139233/15A patent/RU2011139233A/ru unknown
- 2010-04-12 PT PT12155472T patent/PT2497461T/pt unknown
- 2010-04-12 PT PT107172637T patent/PT2421504T/pt unknown
- 2010-04-12 NZ NZ594592A patent/NZ594592A/xx unknown
- 2010-04-12 LT LTEP10717263.7T patent/LT2421504T/lt unknown
- 2010-04-12 PL PL12155472T patent/PL2497461T5/pl unknown
- 2010-04-12 BR BRPI1015447A patent/BRPI1015447B1/pt active IP Right Grant
- 2010-04-12 EP EP12155472.9A patent/EP2497461B2/fr active Active
- 2010-04-12 US US13/265,739 patent/US20120035270A1/en not_active Abandoned
- 2010-04-12 LT LTEP12155472.9T patent/LT2497461T/lt unknown
- 2010-04-12 EP EP10717263.7A patent/EP2421504B2/fr active Active
- 2010-04-12 SG SG2011050663A patent/SG172960A1/en unknown
- 2010-04-12 WO PCT/IB2010/051573 patent/WO2010122442A1/fr not_active Ceased
- 2010-04-12 PL PL10717263.7T patent/PL2421504T5/pl unknown
- 2010-04-12 MX MX2011010766A patent/MX337463B/es active IP Right Grant
- 2010-04-12 ES ES10717263T patent/ES2623936T5/es active Active
- 2010-04-12 DK DK10717263.7T patent/DK2421504T4/da active
- 2010-04-12 DK DK12155472.9T patent/DK2497461T4/da active
- 2010-04-12 ES ES12155472T patent/ES2685178T5/es active Active
- 2010-04-12 AU AU2010240551A patent/AU2010240551B2/en active Active
- 2010-04-12 RS RS20181036A patent/RS57668B2/sr unknown
- 2010-04-12 HU HUE10717263A patent/HUE034581T2/en unknown
- 2010-04-12 EP EP18174428.5A patent/EP3384899A1/fr active Pending
- 2010-04-12 CA CA2755175A patent/CA2755175C/fr active Active
- 2010-04-20 AR ARP100101299A patent/AR076338A1/es not_active Application Discontinuation
- 2010-04-20 TW TW099112270A patent/TWI429459B/zh active
- 2010-12-04 UA UAA201112317A patent/UA107570C2/ru unknown
2011
- 2011-07-15 TN TN2011000350A patent/TN2011000350A1/fr unknown
- 2011-07-28 CO CO11095137A patent/CO6410278A2/es not_active Application Discontinuation
- 2011-08-15 IL IL214674A patent/IL214674A/en active IP Right Grant
- 2011-10-21 CL CL2011002634A patent/CL2011002634A1/es unknown
2014
- 2014-12-01 US US14/556,861 patent/US20150087719A1/en not_active Abandoned
2017
- 2017-05-31 CY CY20171100562T patent/CY1119390T1/el unknown
2018
- 2018-09-03 HR HRP20181408TT patent/HRP20181408T4/hr unknown
- 2018-09-07 CY CY181100939T patent/CY1120667T1/el unknown
2019
- 2019-07-25 AR ARP190102095A patent/AR117621A2/es unknown

Also Published As

Publication number	Publication date
RS57668B2 (sr)	2022-03-31
PL2421504T5 (pl)	2023-01-02
BRPI1015447A2 (pt)	2016-04-19
SI2497461T2 (sl)	2022-04-29
RS57668B1 (sr)	2018-11-30
HRP20181408T1 (hr)	2018-11-02
HUE039937T2 (hu)	2019-02-28
AR117621A2 (es)	2021-08-18
BRPI1015447A8 (pt)	2017-10-03
ES2685178T3 (es)	2018-10-05
EP2246044A1 (fr)	2010-11-03
SI2421504T1 (sl)	2017-06-30
ES2623936T3 (es)	2017-07-12
CL2011002634A1 (es)	2012-06-08
HRP20181408T4 (hr)	2022-03-04
EP2421504A1 (fr)	2012-02-29
RU2011139233A (ru)	2013-05-27
DK2497461T3 (en)	2018-09-03
IL214674A (en)	2017-01-31
JP5695029B2 (ja)	2015-04-01
MX337463B (es)	2016-03-07
PT2497461T (pt)	2018-10-23
GEP20146087B (en)	2014-05-13
DK2421504T4 (da)	2022-11-14
KR20120015305A (ko)	2012-02-21
CN102405041A (zh)	2012-04-04
PL2497461T3 (pl)	2018-12-31
MA33003B1 (fr)	2012-01-02
NZ594592A (en)	2013-11-29
TW201039862A (en)	2010-11-16
CA2755175A1 (fr)	2010-10-28
AU2010240551B2 (en)	2015-07-16
HRP20170610T1 (hr)	2017-07-28
SG172960A1 (en)	2011-08-29
EP2497461A3 (fr)	2014-01-01
CY1120667T1 (el)	2019-12-11
UA107570C2 (xx)	2015-01-26
CY1119390T1 (el)	2018-02-14
EP2497461B1 (fr)	2018-06-20
EP2421504B1 (fr)	2017-03-08
JP2012524773A (ja)	2012-10-18
PT2421504T (pt)	2017-06-16
US20150087719A1 (en)	2015-03-26
AU2010240551A1 (en)	2011-08-04
WO2010122442A1 (fr)	2010-10-28
SI2497461T1 (sl)	2018-10-30
EP2497461B2 (fr)	2021-12-15
PL2421504T3 (pl)	2017-08-31
EP2421504B2 (fr)	2022-08-10
KR101713866B1 (ko)	2017-03-09
CO6410278A2 (es)	2012-03-30
MX2011010766A (es)	2011-10-21
HUE034581T2 (en)	2018-02-28
LT2421504T (lt)	2017-06-12
DK2421504T3 (en)	2017-05-01
HRP20170610T4 (hr)	2022-12-09
US20120035270A1 (en)	2012-02-09
LT2497461T (lt)	2018-10-10
TWI429459B (zh)	2014-03-11
AR076338A1 (es)	2011-06-01
ES2685178T5 (es)	2022-04-13
RS55862B2 (sr)	2022-12-30
RS55862B1 (sr)	2017-08-31
EP2497461A2 (fr)	2012-09-12
EP3384899A1 (fr)	2018-10-10
BRPI1015447B1 (pt)	2020-01-28
CA2755175C (fr)	2018-01-02
DK2497461T4 (da)	2022-02-14
ES2623936T5 (es)	2022-11-28
IL214674A0 (en)	2011-09-27
PL2497461T5 (pl)	2022-06-27

Publication	Publication Date	Title
TN2011000350A1 (en)	2013-03-27	Paediatric solutions comprising a beta-blocker
WO2009089494A3 (fr)	2010-01-14	Compositions pharmaceutiques
IN2012DN01869A (fr)	2015-08-21
WO2012142210A3 (fr)	2012-12-27	Agencement de lange pour bébés
HUE056636T2 (hu)	2022-02-28	Cisz-1,1,1,4,4,4-hexafluor-2-butén azeotróp-jellegû készítményei
ZA201101814B (en)	2016-10-26	Prevention, treatment and diagnosis of p.gingivalis infection
NZ589517A (en)	2012-09-28	A pharmaceutical composition comprising rebamipide
WO2012116010A3 (fr)	2012-10-26	Inhibiteurs de la tolérance aux antibiotiques
WO2010118866A8 (fr)	2010-12-29	Composition contenant du trehalulose, sa preparation et son utilisation
AU2009347008A8 (en)	2012-12-13	Method of preventing diarrhoea
WO2012104240A3 (fr)	2014-05-22	Utilisation cosmétique
WO2010117979A3 (fr)	2011-02-17	Inhibiteur de la recapture de la sérotonine-noradrénaline
WO2010134048A3 (fr)	2012-01-12	Solutions de rétinoïdes topiques
WO2011000581A3 (fr)	2011-05-26	Composition de raloxifène
BRPI0917699A2 (pt)	2015-08-04	Composição herbicida aquosa, e, composição de matéria
WO2012065028A3 (fr)	2012-07-26	Tétracyclines substituées
WO2010075086A3 (fr)	2010-10-14	Inhibiteurs de type pyrrolidinone de pde-4
AP2011005812A0 (en)	2011-08-31	Anti dengue activity of cissampelos pareira extracts.
WO2010118286A3 (fr)	2011-02-24	Modulateurs de l'activité des récepteurs h1 et/ou de la protéine ns4b à base de benzimidazole
WO2010056741A3 (fr)	2010-10-14	Inhibiteurs de cyclooxygénase à base d'acide phénylacétique
WO2010031096A8 (fr)	2010-06-17	Composition à action antimicrobienne et antivirale
AP2012006129A0 (en)	2012-02-29	Benzamide derivatives, preparation and use thereof.
EP2314277A4 (fr)	2015-06-03	Préparation externe pour la peau, et agent de réparation des rides
EP2650363A4 (fr)	2014-10-15	Procédé de purification et de stabilisation de l'enzyme gluconate déshydrogénase (gadh, ec 1.1.99.3), enzyme gluconate déshydrogénase (gadh, ec 1.1.99.3), et utilisation de l'enzyme gluconate déshydrogénase (gadh, ec 1.1.99.3)
曾桦	2009	The First Time I Went on a Plane